Mayer EL - Search Results

1

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer.

Lin NU, Seah DS, Gelman R, Desantis S, Mayer EL, Isakoff S, Dipiro P, Krop IE, Come SE, Weckstein D, Winer EP, Burstein HJ. Lin NU, et al. Among authors: mayer el. Breast Cancer Res Treat. 2013 Jun;139(2):403-10. doi: 10.1007/s10549-013-2551-9. Epub 2013 May 5. Breast Cancer Res Treat. 2013. PMID: 23645007 Clinical Trial.

2

Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.

Burstein HJ, Mayer E, Patridge AH, O'Kane H, Litsas G, Come SE, Hudis CA, Goldstein DF, Muss HB, Winter EP, Garber JE. Burstein HJ, et al. Clin Breast Cancer. 2006 Jun;7(2):158-61. doi: 10.3816/cbc.2006.n.026. Clin Breast Cancer. 2006. PMID: 16800976

3

Novel approaches to advanced breast cancer: bevacizumab and lapatinib.

Mayer EL, Lin NU, Burstein HJ. Mayer EL, et al. J Natl Compr Canc Netw. 2007 Mar;5(3):314-23. doi: 10.6004/jnccn.2007.0026. J Natl Compr Canc Netw. 2007. PMID: 17439759 Review.

4

Chemotherapy for metastatic breast cancer.

Mayer EL, Burstein HJ. Mayer EL, et al. Hematol Oncol Clin North Am. 2007 Apr;21(2):257-72. doi: 10.1016/j.hoc.2007.03.001. Hematol Oncol Clin North Am. 2007. PMID: 17512448 Review.

5

Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer.

Mayer EL, Carey LA, Burstein HJ. Mayer EL, et al. Breast Cancer Res. 2007;9(5):110. doi: 10.1186/bcr1755. Breast Cancer Res. 2007. PMID: 17888189 Free PMC article.

6

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.

Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Partridge AH, et al. J Clin Oncol. 2008 Feb 1;26(4):556-62. doi: 10.1200/JCO.2007.11.5451. Epub 2008 Jan 7. J Clin Oncol. 2008. PMID: 18180462

7

Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer.

Mayer EL, Burstein HJ. Mayer EL, et al. J Clin Oncol. 2008 Mar 10;26(8):1198-200. doi: 10.1200/JCO.2007.14.8734. J Clin Oncol. 2008. PMID: 18323544 No abstract available.

8

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.

Mayer EL, Partridge AH, Harris LN, Gelman RS, Schumer ST, Burstein HJ, Winer EP. Mayer EL, et al. Breast Cancer Res Treat. 2009 Oct;117(3):615-23. doi: 10.1007/s10549-009-0366-5. Epub 2009 Mar 18. Breast Cancer Res Treat. 2009. PMID: 19294501 Free PMC article. Clinical Trial.

9

SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer.

Mayer EL, Dhakil S, Patel T, Sundaram S, Fabian C, Kozloff M, Qamar R, Volterra F, Parmar H, Samant M, Burstein HJ. Mayer EL, et al. Ann Oncol. 2010 Dec;21(12):2370-2376. doi: 10.1093/annonc/mdq260. Epub 2010 May 23. Ann Oncol. 2010. PMID: 20497961 Free article. Clinical Trial.

10

Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.

Mayer EL, Krop IE. Mayer EL, et al. Clin Cancer Res. 2010 Jul 15;16(14):3526-32. doi: 10.1158/1078-0432.CCR-09-1834. Clin Cancer Res. 2010. PMID: 20634194 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters